{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:00:36Z","timestamp":1782316836186,"version":"3.54.5"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ijbiomac.2024.129562","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:12:35Z","timestamp":1705709555000},"page":"129562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"P2","title":["Peptide-ligand conjugate based immunotherapeutic approach for targeted dismissal of non-structural protein 1 of dengue virus: A novel therapeutic solution for mild and severe dengue infections"],"prefix":"10.1016","volume":"260","author":[{"given":"Varshita","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Godara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudip Prasad","family":"Jena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswajit","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay Kumar","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhaneswar","family":"Prusty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijbiomac.2024.129562_bb0005","article-title":"Dengue as a disease threatening Global Health: a narrative review focusing on Latin America and Brazil","volume":"8","author":"Lessa","year":"2023","journal-title":"Trop Med Infect. Dis."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.129562_bb0010","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3390\/tropicalmed6040180","article-title":"Current trends and limitations in dengue antiviral research","volume":"6","author":"Obi","year":"2021","journal-title":"Tropical Medicine and Infectious Disease"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.129562_bb0015","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.3390\/cimb45060291","article-title":"Experimental dengue virus type 4 infection increases the expression of MicroRNAs-15\/16, triggering a caspase-induced apoptosis pathway","volume":"45","author":"Casseb","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129562_bb0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-virology-101416-041848","article-title":"The good, the bad, and the shocking: the multiple roles of dengue virus nonstructural protein 1 in protection and pathogenesis","volume":"5","author":"Glasner","year":"2018","journal-title":"Annu Rev Virol"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.129562_bb0025","article-title":"Flavivirus NS1 and its potential in vaccine development","volume":"9","author":"Carpio","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"15","key":"10.1016\/j.ijbiomac.2024.129562_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155262","article-title":"Mechanisms of action for small molecules revealed by structural biology in drug discovery","volume":"21","author":"Li","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.129562_bb0035","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02440-21","article-title":"Human monoclonal antibodies against NS1 protein protect against lethal West Nile virus infection","volume":"12","author":"Wessel","year":"2021","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129562_bb0040","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1038\/s41467-018-07667-z","article-title":"Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection","volume":"9","author":"Jayathilaka","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129562_bb0045","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1038\/s41467-020-19386-5","article-title":"A universal dual mechanism immunotherapy for the treatment of influenza virus infections","volume":"11","author":"Liu","year":"2020","journal-title":"Nat. Commun."},{"issue":"Pt A","key":"10.1016\/j.ijbiomac.2024.129562_bb0050","article-title":"Rational designing of peptide-ligand conjugates-based immunotherapy for the treatment of complicated malaria","volume":"311","author":"Godara","year":"2022","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.129562_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7006a1","article-title":"Dengue vaccine: recommendations of the advisory committee on immunization practices, United States, 2021","volume":"70","author":"Paz-Bailey","year":"2021","journal-title":"MMWR Recomm. Rep."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.129562_bb0060","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1074\/jbc.M411122200","article-title":"Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp","volume":"280","author":"Mori","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2024.129562_bb0065","series-title":"Identification of FDA-Approved Drugs with Triple Targeting Mode of Action for the Treatment of Monkeypox: A High Throughput Virtual Screening Study","author":"Srivastava","year":"2022"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129562_bb0070","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tay108","article-title":"Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers","volume":"25","author":"Lindsey","year":"2018","journal-title":"J. Travel Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.129562_bb0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.129562_bb0080","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.5716","article-title":"Inhibitory effect of microalgae and cyanobacteria extracts on influenza virus replication and neuraminidase activity","volume":"6","author":"Silva","year":"2018","journal-title":"PeerJ"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.129562_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/toxins15040239","article-title":"High-throughput IgG epitope mapping of tetanus neurotoxin: implications for immunotherapy and vaccine design","volume":"15","author":"De-Simone","year":"2023","journal-title":"Toxins (Basel)"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.129562_bb0090","article-title":"Epitope mapping of the diphtheria toxin and development of an ELISA-specific diagnostic assay","volume":"9","author":"De-Simone","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijbiomac.2024.129562_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijbiomac.2020.05.184","article-title":"High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment","volume":"160","author":"Naik","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.129562_bb0100","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s42770-022-00697-2","article-title":"Anti-DENV-NS1 monoclonal antibody for the differential histopathological diagnosis of hemorrhagic fever caused by dengue","volume":"53","author":"Kanamura","year":"2022","journal-title":"Braz. J. Microbiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129562_bb0105","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1038\/s41467-020-19386-5","article-title":"A universal dual mechanism immunotherapy for the treatment of influenza virus infections","volume":"11","author":"Liu","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129562_bb0110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0003-2697(87)90220-X","article-title":"Computer prediction of potential immunogenic determinants from protein amino acid sequence","volume":"165","author":"Krchn\u00e1k","year":"1987","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.129562_bb0115","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.4314\/ahs.v21i3.23","article-title":"Diphtheria serology in adults in Central Java and East Java, Indonesia: the importance of continuous diphtheria vaccination","volume":"21","author":"Sunarno","year":"2021","journal-title":"Afr. Health Sci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.129562_bb0120","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3346\/jkms.2010.25.12.1727","article-title":"Immunogenicity and safety of diphtheria-tetanus vaccine in adults","volume":"25","author":"Choi","year":"2010","journal-title":"J. Korean Med. Sci."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.129562_bb0125","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.vaccine.2020.01.065","article-title":"Isolation and characterization of new human carrier peptides from two important vaccine immunogens","volume":"38","author":"Wantuch","year":"2020","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2024.129562_bb0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00231366","article-title":"Type-specific immunodetection of human heart fatty acid-binding protein with polyclonal anti-peptide antibodies","volume":"98","author":"Kleine","year":"1990","journal-title":"Mol. Cell. Biochem."},{"issue":"12 Pt 1","key":"10.1016\/j.ijbiomac.2024.129562_bb0135","first-page":"6029","article-title":"Detection of activated Mr 21,000 protein, the product of ras oncogenes, using antibodies with specificity for amino acid 12","volume":"46","author":"Wong","year":"1986","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.129562_bb0140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4161\/mabs.2.3.11779","article-title":"Therapeutic antibodies, vaccines and antibodyomes","volume":"2","author":"Dimitrov","year":"2010","journal-title":"MAbs"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129562_bb0145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jmb.2003.09.054","article-title":"The remarkable flexibility of the human antibody repertoire; isolation of over one thousand different antibodies to a single protein, BLyS","volume":"334","author":"Edwards","year":"2003","journal-title":"J Mol Biol"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129562_bb0150","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41598-019-57103-5","article-title":"Human antibodies neutralizing diphtheria toxin in vitro and in vivo","volume":"10","author":"Wenzel","year":"2020","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.129562_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045152","article-title":"SVMTriP: a method to predict antigenic epitopes using support vector machine to integrate tri-peptide similarity and propensity","volume":"7","author":"Yao","year":"2012","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.129562_bb0160","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prot.10613","article-title":"A hierarchical approach to all-atom protein loop prediction","volume":"55","author":"Jacobson","year":"2004","journal-title":"Proteins: Struct., Funct., Bioinf."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.129562_bb0165","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1039\/C9MD00458K","article-title":"Application of triazoles as bioisosteres and linkers in the development of microtubule targeting agents","volume":"11","author":"Malik","year":"2020","journal-title":"RSC Med Chem"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.129562_bb0170","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/protein\/4.2.155","article-title":"Correlation between stability of a protein and its dipeptide composition: a novel approach for predicting in vivo stability of a protein from its primary sequence","volume":"4","author":"Guruprasad","year":"1990","journal-title":"Protein Eng. Des. Sel."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.129562_bb0175","first-page":"1895","article-title":"Thermostability and aliphatic index of globular proteins","volume":"88","author":"Ikai","year":"1980","journal-title":"The Journal of Biochemistry"},{"key":"10.1016\/j.ijbiomac.2024.129562_bb0180","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34202","article-title":"Local and global influences on protein turnover in neurons and glia","volume":"7","author":"D\u00f6rrbaum","year":"2018","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.129562_bb0185","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/bioinformatics\/btv674","article-title":"Accurate estimation of isoelectric point of protein and peptide based on amino acid sequences","volume":"32","author":"Audain","year":"2016","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129562_bb0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","article-title":"A simple method for displaying the hydropathic character of a protein","volume":"157","author":"Kyte","year":"1982","journal-title":"J. Mol. Biol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.129562_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073957","article-title":"In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PloS One"},{"issue":"Suppl. 6","key":"10.1016\/j.ijbiomac.2024.129562_bb0200","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1471-2105-14-S6-S4","article-title":"AllerTOP--a server for in silico prediction of allergens","volume":"14","author":"Dimitrov","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ijbiomac.2024.129562_bb0205","series-title":"The Proteomics Protocols Handbook","first-page":"571","article-title":"Protein identification and analysis tools on the ExPASy server","author":"Gasteiger","year":"2005"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.129562_bb0210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/protein\/4.2.155","article-title":"Correlation between stability of a protein and its dipeptide composition: a novel approach for predicting in vivo stability of a protein from its primary sequence","volume":"4","author":"Guruprasad","year":"1990","journal-title":"Protein Eng."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.129562_bb0215","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pKaprediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.129562_bb0220","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr. Comput. Aided Drug Des."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129562_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-07308-3","article-title":"Antibodies against modified NS1 wing domain peptide protect against dengue virus infection","volume":"7","author":"Lai","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.129562_bb0230","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.129562_bb0235","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129562_bb0240","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J. Chem. Theory Comput."},{"issue":"60","key":"10.1016\/j.ijbiomac.2024.129562_bb0245","doi-asserted-by":"crossref","first-page":"38079","DOI":"10.1039\/D1RA07377J","article-title":"Docking studies and molecular dynamics simulation of triazole benzene sulfonamide derivatives with human carbonic anhydrase IX inhibition activity","volume":"11","author":"Gaa","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijbiomac.2024.129562_bb0250","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fchem.2020.00571","article-title":"Peptide-drug conjugates and their targets in advanced cancer therapies","volume":"8","author":"Hoppenz","year":"2020","journal-title":"Front. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129562_bb0255","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1021\/acs.jmedchem.0c01530","article-title":"Peptide-drug conjugates with different linkers for Cancer therapy","volume":"64","author":"Alas","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.129562_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121121","article-title":"Rational designing of peptide-ligand conjugates-based immunotherapy for the treatment of complicated malaria","volume":"311","author":"Godara","year":"2022","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129562_bb0265","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1021\/bc5005262","article-title":"Long-Term Stabilization of Maleimide\u2013Thiol Conjugates","volume":"26","author":"Fontaine","year":"2015","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129562_bb0270","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2024.129562_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114322","article-title":"Characterization and impact of peptide physicochemical properties on oral and subcutaneous delivery","volume":"186","author":"Klepach","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.129562_bb0280","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.4155\/tde.13.104","article-title":"Basics and recent advances in peptide and protein drug delivery","volume":"4","author":"Bruno","year":"2013","journal-title":"Ther. Deliv."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.129562_bb0285","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/bcp.12468","article-title":"Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approaches","volume":"78","author":"Beaumont","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.129562_bb0290","first-page":"1","article-title":"Structure-based virtual screening approach reveals natural multi-target compounds for the development of antimalarial drugs to combat drug resistance","author":"Naik","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2024.129562_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105375","article-title":"High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19","volume":"151","author":"Ojha","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"issue":"19","key":"10.1016\/j.ijbiomac.2024.129562_bb0300","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1080\/07391102.2021.1931451","article-title":"Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications","volume":"40","author":"Naik","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2024.129562_bb0305","first-page":"1","article-title":"Identification of FDA-approved drugs with triple targeting mode of action for the treatment of monkeypox: a high throughput virtual screening study","author":"Srivastava","year":"2023","journal-title":"Mol. Divers."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.129562_bb0310","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/07391102.2016.1161560","article-title":"Exploring dual inhibitory role of febrifugine analogues against plasmodium utilizing structure-based virtual screening and molecular dynamic simulation","volume":"35","author":"Pandey","year":"2017","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.129562_bb0315","doi-asserted-by":"crossref","first-page":"11407","DOI":"10.1021\/acsomega.8b01524","article-title":"Molecular dynamics simulations of the interactions between glial cell line-derived neurotrophic factor family receptor GFR\u03b11 and small-molecule ligands","volume":"3","author":"Ivanova","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2024.129562_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijbiomac.2020.05.184","article-title":"High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment","volume":"160","author":"Naik","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129562_bb0325","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1021\/acs.jmedchem.0c01530","article-title":"Peptide\u2013drug conjugates with different linkers for cancer therapy","volume":"64","author":"Alas","year":"2020","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129562_bb0330","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3762\/bjoc.14.64","article-title":"Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin\u2013GnRH-III conjugates developed for targeted drug delivery","volume":"14","author":"Schuster","year":"2018","journal-title":"Beilstein J. Org. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.129562_bb0335","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/imm.13019","article-title":"Basics of memory B-cell responses: lessons from and for the real world","volume":"156","author":"Wong","year":"2019","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.129562_bb0340","article-title":"Factors influencing persistence of diphtheria immunity and immune response to a booster dose in healthy Slovak adults","volume":"7","author":"Petr\u00e1\u0161","year":"2019","journal-title":"Vaccines (Basel)"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.129562_bb0345","article-title":"Seroepidemiology of tetanus among healthy people aged 1-59 years old in Shaanxi Province, China","volume":"10","author":"Zhang","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.129562_bb0350","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/infdis\/jiab480","article-title":"Waning immunity after receipt of pertussis, diphtheria, tetanus, and polio-related vaccines: a systematic review and Meta-analysis","volume":"225","author":"Gao","year":"2022","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.129562_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082967","article-title":"Recall responses to tetanus and diphtheria vaccination are frequently insufficient in elderly persons","volume":"8","author":"Weinberger","year":"2013","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.129562_bb0360","article-title":"Comparison of Immunogenicity and Safety of Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus influenza B (Bio Farma) with Pentabio(\u00ae) Vaccine Primed with Recombinant Hepatitis B at Birth (Using Different Source of Hepatitis B) in Indonesian Infants","volume":"11","author":"Fadlyana","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.129562_bb0365","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"24","key":"10.1016\/j.ijbiomac.2024.129562_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246289","article-title":"Peptide antibodies and more","volume":"20","author":"Trier","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3\u20136","key":"10.1016\/j.ijbiomac.2024.129562_bb0375","article-title":"State of the art in epitope mapping and opportunities in COVID-19","volume":"16","author":"Hamed","year":"2023","journal-title":"Future Sci OA"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.129562_bb0380","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00704-22","article-title":"The dengue virus nonstructural protein 1 (NS1) interacts with the putative epigenetic regulator DIDO1 to promote Flavivirus replication in mosquito cells","volume":"96","author":"Caraballo","year":"2022","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129562_bb0385","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-virology-101416-041848","article-title":"The good, the bad, and the shocking: the multiple roles of dengue virus nonstructural protein 1 in protection and pathogenesis","volume":"5","author":"Glasner","year":"2018","journal-title":"Annual Review of Virology"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.129562_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15061648","article-title":"Targeting Peptides: the new generation of targeted drug delivery systems","volume":"15","author":"Todaro","year":"2023","journal-title":"Pharmaceutics"},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.129562_bb0395","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27217232","article-title":"Peptide-drug conjugates: a new hope for cancer management","volume":"27","author":"Chavda","year":"2022","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.129562_bb0400","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1016\/j.apsb.2023.02.013","article-title":"Research advances in peptide\u2013drug conjugates","volume":"13","author":"Gong","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.129562_bb0405","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.apsb.2022.07.020","article-title":"Peptide-drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?","volume":"13","author":"Fu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.129562_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010469","article-title":"Therapeutic efficacy of humanized monoclonal antibodies targeting dengue virus nonstructural protein 1 in the mouse model","volume":"18","author":"Tien","year":"2022","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129562_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"27","author":"Lu","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ijbiomac.2024.129562_bb0420","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/bs.ai.2021.08.003","article-title":"Antibody dependent enhancement: Unavoidable problems in vaccine development","volume":"151","author":"Xu","year":"2021","journal-title":"Adv. Immunol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.129562_bb0425","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41591-021-01282-0","article-title":"Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases","volume":"27","author":"Meganck","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2024.129562_bb0430","doi-asserted-by":"crossref","first-page":"1135541","DOI":"10.3389\/fmed.2023.1135541","article-title":"Immunotherapies against human bacterial and fungal infectious diseases: a review","volume":"10","author":"Qadri","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129562_bb0435","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ab.2005.07.033","article-title":"Cell-penetrating peptides: a comparative membrane toxicity study","volume":"345","author":"Saar","year":"2005","journal-title":"Anal. Biochem."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024003659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024003659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:13:47Z","timestamp":1758885227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024003659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":87,"alternative-id":["S0141813024003659"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129562","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptide-ligand conjugate based immunotherapeutic approach for targeted dismissal of non-structural protein 1 of dengue virus: A novel therapeutic solution for mild and severe dengue infections","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129562","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129562"}}